Torrent Pharmaceuticals — Q2 FY2025-26 Earnings Presentation

4 slides from Torrent Pharmaceuticals's earnings presentation, Nov 7, 2025

Slide 1: Presentation to analysts on unaudited consolidated financial results
07th November, 2025 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla
Slide 2: Q2 FY 2025-26 Revenues: Summary
Q2 FY 2025-26 Revenues: Summary 1
Slide 3: Revenue: Summary (Q2 FY26)
Revenue: Summary Revenues (Rs cr) Q2 FY26 Q2 FY25 Gr% India 1820 1632 12% United States 337 268 26% Germany 303 288 5% Brazil 318 263 21% Others 524 438 20% Total 3302 2889 14% 2
Slide 4: Revenue: Summary (H1 FY26)
Revenue: Summary Revenues (Rs cr) H1 FY26 H1 FY25 Gr% India 3631 3267 11% United States 646 527 23% Germany 612 572 7% Brazil 536 459 17% Others 1055 923 14% Total 6480 5748 13% 3